Yayınlar & Eserler

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

The impact of previous SARS-CoV-2 infection on post-vaccine adverse events in individuals vaccinated with TURKOVAC or CoronaVac -inactivated COVID-19 vaccines

DURUSU TANRIÖVER M., Aydin O. A., GÜNER H. R., YILDIZ O., Celik I., Kose S., et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS , sa.1, 2024 (SCI-Expanded) identifier identifier

Crimean–Congo Hemorrhagic Fever Virus: Progress in Vaccine Development

ÖZDARENDELİ A.
Diagnostics , cilt.13, sa.16, 2023 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study

Ates I., Batirel A., Aydin M., Karadag F. Y., Erden A., KÜÇÜKŞAHİN O., et al.
Vaccines , cilt.11, sa.7, 2023 (SCI-Expanded) Creative Commons License identifier identifier identifier

SARS-CoV-2 spike protein S1 subunit induces potent neutralizing responses in mice and is effective against Delta and Omicron variants

Mamedov T., Yuksel D., Gurbuzaslan I., Gulec B., Mammadova G., Özdarendeli A., et al.
Frontiers in Plant Science , cilt.14, 2023 (SCI-Expanded) Creative Commons License identifier identifier identifier

A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO (TM))

GÜL F., GÖNEN Z. B., Jones O. Y., Taşlı N. P., ZARARSIZ G., ÜNAL E., et al.
FRONTIERS IN IMMUNOLOGY , cilt.13, 2022 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial

DURUSU TANRIÖVER M., Aydin O. A., Guner R., YILDIZ O., Celik I., Doganay H. L., et al.
VACCINES , cilt.10, sa.11, 2022 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Development of a protective inactivated vaccine against Crimean-Congo hemorrhagic fever infection

Berber E., Çanakoğlu N., Tonbak Ş., Ozdarendeli A.
HELIYON , cilt.7, sa.10, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

The Seroprevalence of Crimean-Congo Hemorrhagic Fever in Wild and Domestic Animals: An Epidemiological Update for Domestic Animals and First Seroevidence in Wild Animals from Turkiye

Nurettin C., Engin B., Sukru T., Munir A., Zati V., Aykut O.
VETERINARY SCIENCES , cilt.9, sa.9, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier

Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2

Yetişkin H., Kaplan B., Pavel S. T. I., Özdarendeli A.
FRONTIERS IN IMMUNOLOGY , cilt.13, ss.824378, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.

Taşlı N. P., Gönen Z. B., Kırbaş O. K., Gökdemir N. S., Bozkurt B. T., Bayrakçı B., et al.
FRONTIERS IN IMMUNOLOGY , cilt.13, ss.1-15, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Turkey: A randomized trial

Omma A., Batirel A., Aydin M., Karadag F. Y., Erden A., KÜÇÜKŞAHİN O., et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS , cilt.18, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Immune responses in multiple hosts to Nucleocapsid Protein (NP) of Crimean-Congo Hemorrhagic Fever Virus (CCHFV)

Karaaslan E., ÇETİN N. S., Kalkan-Yazıcı M., Hasanoğlu S., KARAKEÇİLİ F., ÖZDARENDELİ A., et al.
PLoS Neglected Tropical Diseases , cilt.15, sa.12, 2021 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in Nicotiana benthamiana Plant as a Vaccine Candidate against COVID-19

Mamedov T., Yuksel D., Ilgın M., Gürbüzaslan I., Gulec B., Mammadova G., et al.
VACCINES , cilt.9, sa.11, 2021 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Development of an Inactivated Vaccine against SARS CoV-2

Pavel S. T. I., Yetiskin H., Uygut M. A., Aslan A. F., Aydın G., Inan Ö., et al.
VACCINES , cilt.9, sa.11, 2021 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice

Mamedov T., Yuksel D., Ilgın M., Gurbuzaslan I., Gulec B., Yetiskin H., et al.
VIRUSES-BASEL , cilt.13, sa.8, 2021 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Development of a novel recombinant ELISA for the detection of Crimean-Congo hemorrhagic fever virus IgG antibodies

Guelce-Iz S., ELALDI N., Can H., Sahar E. A., KARAKAVUK M., Gul A., et al.
SCIENTIFIC REPORTS , cilt.11, sa.1, 2021 (SCI-Expanded) identifier identifier identifier

Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model

Pavel S. T. I., Yetiskin H., Kalkan A., Ozdarendeli A.
PLOS NEGLECTED TROPICAL DISEASES , cilt.14, sa.11, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in Turkey

PAVEL S. T. I., YETİŞKİN H., AYDIN G., Holyavkin C., UYGUT M. A., Dursun Z. B., et al.
PLoS ONE , cilt.15, 2020 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

Alm E., Broberg E. K., Connor T., Hodcroft E. B., Komissarov A. B., Maurer-Stroh S., et al.
Eurosurveillance , cilt.25, sa.32, 2020 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Immunization of Knock-Out alpha/beta Interferon Receptor Mice against High Lethal Dose of Crimean-Congo Hemorrhagic Fever Virus with a Cell Culture Based Vaccine

ÇANAKOĞLU N., Berber E., Tonbak S., ERTEK M., SÖZDUTMAZ I., Aktas M., et al.
PLOS NEGLECTED TROPICAL DISEASES , cilt.9, sa.3, 2015 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Application of the pseudo-plaque assay for detection and titration of Crimean-Congo hemorrhagic fever virus

Berber E., Canakoglu N., Yoruk M. D., Tonbak S., Aktas M., ERTEK M., et al.
JOURNAL OF VIROLOGICAL METHODS , cilt.187, sa.1, ss.26-31, 2013 (SCI-Expanded) identifier identifier identifier

Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus

Canakoglu N., Berber E., ERTEK M., Yoruk M. D., Tonbak S., Bolat Y., et al.
VIROLOGY JOURNAL , cilt.10, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Vectors and Vector-Borne Diseases in Turkey

İNCİ A., Yazar S., TUNÇBİLEK A. Ş., CANHİLAL R., DOĞANAY M., Aydın L., et al.
ANKARA UNIVERSITESI VETERINER FAKULTESI DERGISI , cilt.60, sa.4, ss.281-296, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

The complete genome analysis of Crimean-Congo hemorrhagic fever virus isolated in Turkey

Ozdarendeli A., Canakoglu N., Berber E., Aydin K., Tonbak S., ERTEK M., et al.
VIRUS RESEARCH , cilt.147, sa.2, ss.288-293, 2010 (SCI-Expanded) identifier identifier identifier

Genetic analysis of the M RNA segment of Crimean-Congo hemorrhagic fever virus strains in Turkey

ÖZDARENDELİ A., Aydin K., Tonbak S., Aktas M., Altay K., Koksal I., et al.
ARCHIVES OF VIROLOGY , cilt.153, sa.1, ss.37-44, 2008 (SCI-Expanded) identifier identifier identifier

Crimean-Congo hemorrhagic fever virus: Genetic analysis and tick survey in Turkey

Tonbak S., Aktas M., Altay K., Azkur A. K., Kalkan A., Bolat Y., et al.
JOURNAL OF CLINICAL MICROBIOLOGY , cilt.44, sa.11, ss.4120-4124, 2006 (SCI-Expanded) Creative Commons License identifier identifier identifier

[Genotyping of hepatitis B virus by restriction enzyme analysis].

Aksoy A., Ozdarendeli A.
Mikrobiyoloji bulteni , cilt.40, sa.3, ss.215-23, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

Detection of Molluscum contagiosum virus (MCV) subtype I as a single dominant virus subtype in molluscum lesions from a Turkish population

Saral Y., Kalkan A., ÖZDARENDELİ A., Bulut Y., DOYMAZ M. Z.
ARCHIVES OF MEDICAL RESEARCH , cilt.37, sa.3, ss.388-391, 2006 (SCI-Expanded) identifier identifier identifier

Bovine coronavirus 5 '-proximal genomic acceptor hotspot for discontinuous transcription is 65 nucleotides wide

Wu H., Ozdarendeli A., Brian D.
JOURNAL OF VIROLOGY , cilt.80, sa.5, ss.2183-2193, 2006 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Combined branched-DNA and conventional HBV PCR assays for detection of serum HBV-DNA in hepatitis B e antigen-positive chronic hepatitis B patients

ÖZDARENDELİ A., Toroman Z., Bulut Y., Demirbag K., Kalkan A., Ozden M., et al.
HEPATO-GASTROENTEROLOGY , cilt.53, sa.67, ss.106-109, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Prevalence and genotypic distribution of hepatitis GB-C/HG and TT viruses in blood donors, mentally retarded children and four groups of patients in Eastern Anatolia, Turkey

Kalkan A., ÖZDARENDELİ A., Bulut Y., Saral Y., Ozden M., Kelestimur N., et al.
JAPANESE JOURNAL OF INFECTIOUS DISEASES , cilt.58, sa.4, ss.222-227, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Detection of Helicobacter pylori in children with otitis media with effusion: A preliminary report

Karlidag T., Bulut Y., Keles E., Kaygusuz I., Yalcin S., ÖZDARENDELİ A., et al.
LARYNGOSCOPE , cilt.115, sa.7, ss.1262-1265, 2005 (SCI-Expanded) identifier identifier identifier

Identification of Chlamydia trachomatis with polymerase chain reaction in middle ear fluid in otitis media with effusion

Keles E., Bulut Y., Kaygusuz I., Karlidag T., Yalcin S., ÖZDARENDELİ A., et al.
INDIAN PEDIATRICS , cilt.42, sa.7, ss.686-691, 2005 (SCI-Expanded) identifier identifier identifier

[Molecular identification of Candida albicans and Candida dubliniensis strains isolated from clinical samples].

Toraman Z. A., Bulut Y., Yilmaz M., Ozdarendeli A.
Mikrobiyoloji bulteni , cilt.39, sa.2, ss.199-204, 2005 (SCI-Expanded) identifier identifier

The effect of L-Tryptophan on hemorrhagic shock induced bacterial translocation

Bulbuller N., Pektas B., ÖZDARENDELİ A., Dogru O., Aygen E., Akpolat N.
JOURNAL OF SURGICAL RESEARCH , cilt.123, sa.2, ss.194-199, 2005 (SCI-Expanded) identifier identifier identifier

Investigation of Epstein-Barr virus DNA in formalin-fixed and paraffin-embedded breast cancer tissues

Kalkan A., ÖZDARENDELİ A., Bulut Y., Yekeler H., Cobanoglu B., DOYMAZ M. Z.
MEDICAL PRINCIPLES AND PRACTICE , cilt.14, sa.4, ss.268-271, 2005 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Prevalence and genotypes of hepatitis G virus among hemodialysis patients in Eastern Anatolia, Turkey

ÖZDARENDELİ A., Toroman Z., Kalkan A., Kilic S., Ozden M., DOYMAZ M. Z.
MEDICAL PRINCIPLES AND PRACTICE , cilt.14, sa.2, ss.102-106, 2005 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

SV40 in human thyroid nodules

ÖZDARENDELİ A., Camci C., Aygen E., Kirkil C., Toroman Z., Dogru O., et al.
JOURNAL OF CLINICAL VIROLOGY , cilt.30, sa.4, ss.337-340, 2004 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

The frequency of Toxocara infection in mental retarded children

KAPLAN M., KALKAN A., Hosoglu S., KUK S., Özden M., Demirdag K., et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ , cilt.99, sa.2, ss.121-125, 2004 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

A Case of Mumps Conjunctivitis Detection of the Virus RNA by Nested PCR in Tear Sample

KALKAN A., ÖZDEN M., YILMAZ T., DEMİRDAĞ K., BULUT Y., ÖZDARENDELİ A.
Scandinavian Journal Of Infectious Diseases , cilt.36, sa.9, ss.698-700, 2004 (SCI-Expanded)

Cutaneous anthrax in adults: A review of 25 cases in the eastern Anatolian region of Turkey

Demirdag K., Ozden M., Saral Y., Kalkan A., Kilic S., ÖZDARENDELİ A.
INFECTION , cilt.31, sa.5, ss.327-330, 2003 (SCI-Expanded) identifier identifier identifier

Levels of plasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B.

Demirdag K., Yilmaz S., Ozdarendeli A., Ozden M., Kalkan A., Kilic S. S.
Hepato-gastroenterology , cilt.50, sa.51, ss.766-70, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

Ciprofloxacin and co-trimoxazole resistance and extended spectrum beta-lactamase production in Escherichia coli strains isolated from urinary tract infections

Ozden M., Kalkan A., Demirdag K., Kilic S., ÖZDARENDELİ A.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS , cilt.21, sa.5, ss.492-493, 2003 (SCI-Expanded) identifier identifier identifier

Seropositivity of Epstein-Barr virus in Eastern Anatolian Region of Turkey.

Ozkan A., Kilic S. S., Kalkan A., Ozden M., Demirdag K., Ozdarendeli A.
Asian Pacific journal of allergy and immunology , cilt.21, sa.1, ss.49-53, 2003 (SCI-Expanded) identifier identifier

[Fasciola hepatica seroprevalence in the Elaziğ region].

Kaplan M., Kuk S., Kalkan A., Demirdağ K., Ozdarendeli A.
Mikrobiyoloji bulteni , cilt.36, sa.3-4, ss.337-42, 2002 (SCI-Expanded) identifier identifier

Downstream sequences influence the choice between a naturally occurring noncanonical and closely positioned upstream canonical heptameric fusion motif during bovine coronavirus subgenomic mRNA synthesis

ÖZDARENDELİ A., Ku S., Rochat S., Williams G., Senanayake S., Brian D.
JOURNAL OF VIROLOGY , cilt.75, sa.16, ss.7362-7374, 2001 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Diğer Dergilerde Yayınlanan Makaleler

Overview of Zoonotic Diseases in Turkey: The One Health Concept and Future Threats

Inci A., Doganay M., Ozdarendeli A., Düzlü Ö., Yildirim A.
TÜRKİYE PARAZİTOLOJİ DERGİSİ , cilt.42, ss.39-80, 2018 (Hakemli Dergi)

Overview of Zoonotic Diseases in Turkey: The One Health Concept and Future Threats.

İnci A., Doğanay M., Özdarendeli A., Düzlü Ö., Yıldırım A.
Turkiye parazitolojii dergisi , cilt.42, ss.39-80, 2018 (Hakemli Dergi) Creative Commons License identifier identifier

[Expression of the cathepsin L1 gene of Fasciola hepatica eucaryotic cells].

Kuk S., Kaplan M., Kalkan A., Ozdarendeli A.
Turkiye parazitolojii dergisi , cilt.30, sa.1, ss.25-8, 2006 (Scopus) identifier identifier

Detection of Epstein-Barr virus DNA by polymerase chain reaction in surgical specimens of patients with squamous cell carcinoma of the larynx and vocal cord nodules.

Gök U., Ozdarendeli A., Keleş E., Bulut Y., Cobanoğlu B.
Kulak burun bogaz ihtisas dergisi : KBB = Journal of ear, nose, and throat , cilt.11, sa.5, ss.134-8, 2003 (Scopus) identifier identifier

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Comparing Immunogenicity and Protective Efficacy of Cell Culture Based and Mice Brain Derived Inactivated Vaccine of Crimean Congo Haemorrhagic Fever Virus in Transiently Immune Suppressed Balb/c Mouse Model

YETİŞKİN H., pavel S. T. I., ÖZDARENDELİ A.
ScanVir2019, 3 - 05 Haziran 2019 Sürdürülebilir Kalkınma

S1P1 Agonisti SEW2871 insan Th17 Hücresi gelişim ve fonksiyonlarını doğrudan ve dolaylı etkilemektedir

EKEN A., Okus F. Z., YETKİN M. F., çakır m., ÖZDARENDELİ A., ALTUNTAŞ H., et al.
XXIV. Ulusal İmmünoloji Kongresi, Türkiye, 27 - 30 Nisan 2017

Detailed Immonological Analysıis of Recombinant Crimean Congo Hemorrhagic Fever Virus Nucleoprotein

KARAASLAN E., ÇETİN N. S., Hasanoğlu S., KILIÇ A. O., KALKAN A., ÖZDARENDELİ A., et al.
European Congress of Virology, 28 Nisan - 01 Mayıs 2019

Fingolimod ve SEW2871 insan Th17 hücresi gelişimini etkilemektedir

YETKİN M. F., EKEN A., Okuş F., ÇAKIR M., ÖZDARENDELİ A., ALTUNTAŞ H., et al.
10.Klinik Nöroimmunoloji Sempozyumu, Girne, Kıbrıs (Kktc), 1 - 05 Nisan 2018, ss.34

Discovery of Crimean‐Congo Hemorrhagic Fever Virus vaccine candidate antigens by protein microarray scanning and verification of the determined antigens by recombinant ELISA

GÜLÇE İZ S., DÖŞKAYA M., nakajima r., pablo j., Can H., Atalay Şahar E., et al.
2017 ISV Annual Congress, 5 - 07 Ekim 2017 Sürdürülebilir Kalkınma

Protein Mikroarray Tarama ile Kırım-Kongo Kanamalı Ate şi Virüsüneait a şı adayı antijenlerin ke şfi ve rekombinant ELISA ile do ğrulanması

GÜLÇE İZ S., DÖŞKAYA M., nakajima r., pablo j., jain a., Can H., et al.
20. Ulusal Parazitoloji Kongresi(Uluslararası Katılımlı), 25 - 29 Eylül 2017

Evaluation of CCHFV nucleoprotein as diagnostic tool in ELISA

ÇETİN N. S., KARAASLAN E., YAZICI M., Hasanoğlu S., KALKAN A., KILIÇ A. O., et al.
2nd International Conference on Crimean-Congo Hemorrhagic Fever, 10 - 12 Eylül 2017

S1P1 Agonist SEW2871 Inhibits human Th17 cell generation and functions

EKEN A., Okus F. Z., YETKİN M. F., ÇAKIR M., ÖZDARENDELİ A., MİRZA M.
IMMUNOLOGY2017, Washington Dc, Amerika Birleşik Devletleri, 12 - 16 Mayıs 2017, cilt.198

Direct and indirect effects of S1P1 Agonist SEW2871 on human Th17 cell generation and functions

EKEN A., Okuş F., YETKİN M. F., ÇAKIR M., ÖZDARENDELİ A., ALTUNTAŞ H., et al.
Erciyes Tıp Genetik Günleri, Kayseri, Türkiye, 11 - 15 Mayıs 2017

S1P1 Agonist SEW2871 Inhibits human Th17 cell generation and functions

Eken A., Okus F. Z., Yetkin M. F., Cakir M., Ozdarendeli A., Mirza M.
Annual Meeting of the American-Association-of-Immunologists (AAI), Washington, Kiribati, 12 - 16 Mayıs 2017, cilt.198 identifier

S1P1 Agonisti SEW2871’in insan Th17 hücresi gelişim ve fonksiyonlarını doğrudan ve dolaylı etkilemektedir

EKEN A., Okuş F., YETKİN M. F., ÇAKIR M., ÖZDARENDELİ A., ALTUNTAŞ H., et al.
XXIV. Ulusal İmmunoloji Kongresi, İstanbul, Türkiye, 27 - 30 Nisan 2017

Kırım Kongo Aşı Projesi

ÖZDARENDELİ A.
37. Türk Mikrobiyoloji Kongresi, Türkiye, 16 - 20 Kasım 2016 Sürdürülebilir Kalkınma

Investigation of IFN Response to the Inactivated Vaccine Developed against Crimean Congo Hemorrhagic Fever Virus

BERBER E., SÖZDUTMAZ İ., ÇANAKOĞLU N., ÇALIŞKAN M., ÖZDARENDELİ A.
9th Vaccine & ISV Annual Global Congress, 18 - 20 Ekim 2015 Sürdürülebilir Kalkınma

Investigation of IFN gama Response to the Inactivated Vaccine Developed against Crimean Congo Hemorrhagic Fever Virus

BERBER E., SÖZDUTMAZ İ., ÇANAKOĞLU N., calışkan m., ÖZDARENDELİ A.
9th Vaccine and ISV Congress, 18 - 20 Ekim 2015 Sürdürülebilir Kalkınma

Determination of the Vaccine Induced Immunodominant Regions of Nucleoprotein Crimean CongoHemorrhagic Fever Virus

BERBER E., ÇANAKOĞLU N., SÖZDUTMAZ İ., ÇALIŞKAN M., PAVEL S. T. I., YETİŞKİN H., et al.
ICVID 2015: International Conference on Virology and Infectious Diseases, Londrina, Birleşik Krallık, 25 - 26 Eylül 2015, cilt.2, ss.975 Sürdürülebilir Kalkınma

KIRIM KONGO KANAMALI HASTALIGINA KARSI HUCRE KULTUR TABANLI ASI GELISTIRME CALISMALARI

ÖZDARENDELİ A.
ASI BILIMI KONGRESI, İzmir, Türkiye, 28 - 30 Nisan 2015

Immunization of knock out alpha beta interferon receptor mice against high lethal dose of Crimean Congo hemorrhagic fever virus with a cell culture based vaccine

ÖZDARENDELİ A.
CSCM-World Congress on CBRNe Science and Consequence Management, Zagreb, Hırvatistan, 12 - 17 Nisan 2015 Sürdürülebilir Kalkınma

AŞI ÇALIŞMALARI

ÖZDARENDELİ A.
2. ULUSAL KLİNİK ARAŞTIRMALAR KONGRESİ, Türkiye, 27 - 28 Mart 2015 Sürdürülebilir Kalkınma

A Purified Inactivated Crimean-Congo Hemorrhagic Fever Virus Vaccine Derived from Vero Cells

ÖZDARENDELİ A., BERBER E., Çanakoğlu N., ERTEK M., Tonbak Ş., Sözdutmaz İ., et al.
7th Vaccine&ISV Congress, Barcelona, İspanya, 27 - 29 Ekim 2013, ss.92 Sürdürülebilir Kalkınma

Crimean-Congo Hemorrhagic Fever Infection prevalance in Field Collected Ticks in Endemic Areas of Turkey

AKTAS M., Vatansever Z., Çanakoğlu N., BERBER E., Özübek S., KALKAN A., et al.
5th European Congress of Virology, Lyon, Fransa, 11 - 14 Eylül 2013, ss.189

Kırım Kongo Kanamalı Ateşi Virusuna Karşı Nötralizan Antikor Titresinin Belirlenmesi Amacıyla Pseudo-Plaque Redüksiyon Nötralizasyon Testi Geliştirilmesi

Berber E., Çanakoğlu N., Yörük M. D., Tonbak Ş., Aktaş M., Ertek M., et al.
X. Ulusal Veteriner Hekimleri Mikrobiyoloji Kongresi, Aydın, Türkiye, 24 - 27 Eylül 2012, ss.54 Creative Commons License

İndirekt ELISA Testi ile Sığır, Koyun ve Keçilerde Kırım-Kongo Kanamalı Ateşi Hastalığı Virusunun Seroprevalansının Belirlenmesi

Çanakoğlu N., BERBER E., Yörük M. D., Tonbak Ş., AKTAS M., Vatansever Z., et al.
X. Ulusal Veteriner Hekimleri Mikrobiyoloji Kongresi, Aydın, Türkiye, 24 - 27 Eylül 2012, ss.101

CCHF Infection Prevalence in Field Collected Ticks in Turkey

Vatansever Z., Aktas M., Güven E., Çanakoğlu N., Berber E., Özdarendeli A.
Joint Conference on Emerging and Re-emerging Epidemics Affecting Global Health, Umbria, İtalya, 19 - 22 Eylül 2012, ss.74 Creative Commons License

Development of pseudo-plaque assay for detection and titration of Crimean Congo Hemorrhagic Fever Virus

Berber E., Çanakoğlu N., Yörük M. D., Tonbak Ş., Aktas M., Ertek M., et al.
The 1st Regional STVM 2012 Conference, Phuket, Tayland, 18 - 21 Haziran 2012, ss.100 Creative Commons License

Endemik Bölgede Konak Arayan Kenelerde Kırım-Kongo Kanamalı Ateşi Virüsünün Yaygınlığı

AKTAS M., Çanakoğlu N., BERBER E., Özübek S., Yörük M. D., Vatansever Z., et al.
4. Ulusal Viroloji Kongresi, İstanbul, Türkiye, 23 - 26 Haziran 2011

Kitap & Kitap Bölümleri

İnaktif Viral Aşılar

ÖZDARENDELİ A., PAVEL S. T. I., YETİŞKİN H., UYGUT M. A., KAPLAN B.
AŞI ÇALIŞMALARI VE TEKNOLOJİSİ, Mert Döşkaya ,Adnan Yüksel Gürüz, Ayşe Gülten Kantarcı, Cemal Ün, Editör, Nobel Tıp Kitabevleri Tic. Ltd. Şti., İstanbul, ss.285-298, 2023 Sürdürülebilir Kalkınma

Metrikler

Yayın

80

Atıf (WoS)

594

H-İndeks (WoS)

15

Atıf (Scopus)

801

H-İndeks (Scopus)

17

Proje

29

Fikri Mülkiyet

4

Tez Danışmanlığı

3

Açık Erişim

21
BM Sürdürülebilir Kalkınma Amaçları